6101 Bollinger Canyon Road
Suite 500
San Ramon, CA 94583
United States
925 460 3600
https://www.coopercos.com
Settore/i: Healthcare
Settore: Medical Instruments & Supplies
Impiegati a tempo pieno: 12.000
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Albert G. White III | Pres, CEO & Non-Independent Director | 2,44M | 20,73M | 1970 |
Mr. Brian G. Andrews | Exec. VP, CFO & Treasurer | 971k | 1,55M | 1979 |
Mr. Daniel G. McBride Esq. | Exec. VP & COO | 1,44M | 22,77M | 1964 |
Mr. Agostino Ricupati | Sr. VP of Fin. & Tax and Chief Accounting Officer | 670,71k | 917,72k | 1967 |
Ms. Holly R. Sheffield | Pres of CooperSurgical, Inc. | 1,02M | N/D | 1971 |
Mr. Kim Duncan | VP of Investor Relations & Risk Management | N/D | N/D | N/D |
Mr. Nicholas S. Khadder | Gen. Counsel & Corp. Company | N/D | N/D | 1974 |
Mr. Juan Carlos Aragon | Pres of CooperVision Specialty EyeCare Division | N/D | N/D | N/D |
Mr. Gerard H. Warner III | Pres of CooperVision, Inc. | N/D | N/D | 1965 |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
L'ISS Governance QualityScore di The Cooper Companies, Inc. al 31 luglio 2022 è 4. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 4; diritti degli azionisti: 2; retribuzione: 7.